on 07 Apr 2020
Last Applicant/ Owned by
In den Dauen 6a
Bonn
DE
53117
Serial Number
88278778 filed on 28th Jan 2019
Registration Number
6026619 registered on 07th Apr 2020
Correspondent Address
LEIGH ANN LINDQUIST
Filing Basis
1. intent to use
Disclaimer
NO DATA
Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties; all the aforementioned only in relation to drug delivery agents or systems based on an engineered protein capsule and/or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned for Read More
Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof
Diagnostic preparations for medical purposes; vaccines; pharmaceutical preparations, namely, adjuvants, carriers for active ingredients and drug delivery systems based on an engineered protein capsule for medical use in humans or animals, implants comprising active ingredients for the prevention or treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; all the aforementioned goods only being either drug delivery agents based on an engineered protein capsule or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned goods for use in connection with the treatment or prevention of hepatitis
Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties; all the aforementioned only in relation to drug delivery agents or systems based on an engineered protein capsule and/or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned for use in connection with the treatment or prevention of hepatitis
Scientific research and development for third parties, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development with regard to the manufacture of pharmaceutical preparations, carriers for active ingredients and drug delivery systems for use in humans or animals, for third parties; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for third parties
No 88278778
No Service Mark
No S24052
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Apr 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
26th Apr 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
26th Apr 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
26th Apr 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
26th Apr 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
07th Apr 2020 | REGISTERED-PRINCIPAL REGISTER |
21st Jan 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
21st Jan 2020 | PUBLISHED FOR OPPOSITION |
01st Jan 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
17th Dec 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |